Cortechs.ai | Dr. James Brewer on NeuroQuant

Dr. James Brewer on NeuroQuant

DrJamesBrewer.jpgDr. Brewer is the Chief Medical Advisor for Cortechs.ai and was the first physician to incorporate NeuroQuant® into clinical practice. He assisted in the design of the NeuroQuant reports and in the studies that led to NeuroQuant’s FDA clearance in 2006.

In 2004, he joined the faculty of the University of California, San Diego, where he has a joint appointment in Radiology and Neurosciences. Dr. Brewer sees patients at the University of California, San Diego and the Veterans Affairs Hospital in La Jolla.

Dr. Brewer’s primary research interest is human memory. He uses functional and structural magnetic resonance imaging (MRI) to study memory processes in volunteers with healthy memory and in patients with memory impairment, such as cases caused by Alzheimer’s disease (AD).

Dr. Brewer received his graduate and medical training at Stanford University and his neurology residency training at Johns Hopkins University.

In the webinar below, Dr. Brewer shares his experience using NeuroQuant, and gives an overview how NeuroQuant can help physicians improve their assessment of neurodegenerative disease, such as Alzheimer’s disease, multiple sclerosis, epilepsy, as well brain trauma and brain development.

More Resources

07/09/2026

Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration

Cortechs.ai and Viz.ai partner to tackle multiple sclerosis and other neurodegenerative diseases across Viz.ai’s health system network

07/08/2026

The Hidden Tax on Every Head CT You Read

Why automated, consistent alignment, and the reformats it makes possible, may be the most overlooked upgrade in neuroimaging.

06/23/2026

Helping Our Clients Share Their Success Stories

Learn how Cortechs helps clients share clinical achievements, workflow improvements, and innovation through case studies, testimonials, webinars, and more.

06/15/2026

Alzheimer’s Awareness Month: Bringing Clarity to the Alzheimer’s Care Continuum Through Quantitative Imaging

Explore how quantitative imaging is helping clinicians assess, diagnose, and monitor Alzheimer’s disease and related dementias with greater clarity.

06/08/2026

Cortechs.ai and TAC Center Celebrate One Year of Advancing Neuroimaging Innovation in Peru

TAC Centers Peru is celebrating one year of integrating the NeuroQuant® suite into clinical practice.

06/04/2026

SNMMI 2026: Advancing the Future of Quantitative PET in Dementia Imaging

At SNMMI 2026, Cortechs.ai showcased NeuroQuant® PET and the growing role of quantitative PET imaging in dementia care.
Scroll to Top